» Articles » PMID: 36923490

Sleep Matters: Neurodegeneration Spectrum Heterogeneity, Combustion and Friction Ultrafine Particles, Industrial Nanoparticle Pollution, and Sleep Disorders-Denial is Not an Option

Abstract

Sustained exposures to ubiquitous outdoor/indoor fine particulate matter (PM), including combustion and friction ultrafine PM (UFPM) and industrial nanoparticles (NPs) starting , are linked to early pediatric and young adulthood aberrant neural protein accumulation, including hyperphosphorylated tau (p-tau), beta-amyloid (Aβ), α-synuclein (α syn) and TAR DNA-binding protein 43 (TDP-43), hallmarks of Alzheimer's (AD), Parkinson's disease (PD), frontotemporal lobar degeneration (FTLD), and amyotrophic lateral sclerosis (ALS). UFPM from anthropogenic and natural sources and NPs enter the brain through the nasal/olfactory pathway, lung, gastrointestinal (GI) tract, skin, and placental barriers. On a global scale, the most important sources of outdoor UFPM are motor traffic emissions. This study focuses on the neuropathology heterogeneity and overlap of AD, PD, FTLD, and ALS in older adults, their similarities with the neuropathology of young, highly exposed urbanites, and their strong link with sleep disorders. Critical information includes how this UFPM and NPs cross all biological barriers, interact with brain soluble proteins and key organelles, and result in the oxidative, endoplasmic reticulum, and mitochondrial stress, neuroinflammation, DNA damage, protein aggregation and misfolding, and faulty complex protein quality control. The brain toxicity of UFPM and NPs makes them powerful candidates for early development and progression of fatal common neurodegenerative diseases, all having sleep disturbances. A detailed residential history, proximity to high-traffic roads, occupational histories, exposures to high-emission sources (i.e., factories, burning pits, forest fires, and airports), indoor PM sources (tobacco, wood burning in winter, cooking fumes, and microplastics in house dust), and consumption of industrial NPs, along with neurocognitive and neuropsychiatric histories, are critical. Environmental pollution is a ubiquitous, early, and cumulative risk factor for neurodegeneration and sleep disorders. Prevention of deadly neurological diseases associated with air pollution should be a public health priority.

Citing Articles

Environmental Risk Factors for Parkinson's Disease: A Critical Review and Policy Implications.

Atterling Brolin K, Schaeffer E, Kuri A, Rumrich I, Schumacher Schuh A, Darweesh S Mov Disord. 2024; 40(2):204-221.

PMID: 39601461 PMC: 11832802. DOI: 10.1002/mds.30067.


Single-domain magnetic particles with motion behavior under electromagnetic AC and DC fields are a fatal cargo in Metropolitan Mexico City pediatric and young adult early Alzheimer, Parkinson, frontotemporal lobar degeneration and amyotrophic....

Calderon-Garciduenas L, Cejudo-Ruiz F, Stommel E, Gonzalez-Maciel A, Reynoso-Robles R, Torres-Jardon R Front Hum Neurosci. 2024; 18:1411849.

PMID: 39246712 PMC: 11377271. DOI: 10.3389/fnhum.2024.1411849.


Alzheimer and Parkinson diseases, frontotemporal lobar degeneration and amyotrophic lateral sclerosis overlapping neuropathology start in the first two decades of life in pollution exposed urbanites and brain ultrafine particulate matter and....

Calderon-Garciduenas L, Stommel E, Torres-Jardon R, Hernandez-Luna J, Aiello-Mora M, Gonzalez-Maciel A Front Hum Neurosci. 2024; 17:1297467.

PMID: 38283093 PMC: 10811680. DOI: 10.3389/fnhum.2023.1297467.


History of ALS and the competing theories on pathogenesis: IFCN handbook chapter.

Eisen A, Vucic S, Mitsumoto H Clin Neurophysiol Pract. 2024; 9:1-12.

PMID: 38213309 PMC: 10776891. DOI: 10.1016/j.cnp.2023.11.004.


Associations of air pollution with all-cause dementia, Alzheimer's disease, and vascular dementia: a prospective cohort study based on 437,932 participants from the UK biobank.

Yuan S, Huang X, Zhang L, Ling Y, Tan S, Peng M Front Neurosci. 2023; 17:1216686.

PMID: 37600021 PMC: 10436530. DOI: 10.3389/fnins.2023.1216686.

References
1.
John T, Adler J, Elsner C, Petzold J, Krueger M, Martin L . Mechanistic insights into the size-dependent effects of nanoparticles on inhibiting and accelerating amyloid fibril formation. J Colloid Interface Sci. 2022; 622:804-818. DOI: 10.1016/j.jcis.2022.04.134. View

2.
Boeve B, Silber M, Ferman T, Lin S, Benarroch E, Schmeichel A . Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med. 2013; 14(8):754-62. PMC: 3745815. DOI: 10.1016/j.sleep.2012.10.015. View

3.
Nelson P, Brayne C, Flanagan M, Abner E, Agrawal S, Attems J . Frequency of LATE neuropathologic change across the spectrum of Alzheimer's disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts. Acta Neuropathol. 2022; 144(1):27-44. PMC: 9552938. DOI: 10.1007/s00401-022-02444-1. View

4.
Biswas P, Wu C . Nanoparticles and the environment. J Air Waste Manag Assoc. 2005; 55(6):708-46. DOI: 10.1080/10473289.2005.10464656. View

5.
Valli M, Uribe C, Mihaescu A, Strafella A . Neuroimaging of rapid eye movement sleep behavior disorder and its relation to Parkinson's disease. J Neurosci Res. 2022; 100(10):1815-1833. DOI: 10.1002/jnr.25099. View